Interstitial lung diseases
Clinical trials session
ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: Interstitial lung diseases and pulmonary hypertension
Aims : to present important clinical trials in respiratory medicine; to summarise key findings and discuss with the audience experts conclusions, to bring clinical trial’s abstracts into the clinical context. This session is led by a chair and two expert discussants who will facilitate the discussions and summarise key messages.
Target audience :
Adult pulmonologist/Clinician, Trainee, Clinical researcher, General practitioner, Scientist (basic, translational)
10:45
Late Breaking Abstract - Exploring Efficacy and Safety of oral Pirfenidone for progressive, non-IPF Lung Fibrosis (RELIEF)
A. Guenther(Gießen, Germany)
COI
1
10:55
Late Breaking Abstract - Phase II trial of pirfenidone in patients with progressive fibrosing unclassifiable ILD (uILD)
T. Maher(Los Angeles, United States)
COI
2
11:05
Nintedanib in patients with chronic fibrosing interstitial lung diseases with progressive phenotype: the INBUILD trial
K. Flaherty(Pinckney, United States)
COI
3
11:15
Late Breaking Abstract - Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension: results from the randomised controlled RACE study
X. Jais(Le Kremlin-Bicêtre, France)
COI
4
11:25
Wrap-up by discussant and discussion
M. Kolb(Hamilton (ON), Canada)
COI
5
RCT
11:45
Changes in FVC in the SENSCIS trial of nintedanib in patients with systemic sclerosis-associated ILD (SSc-ILD)
K. Highland(Cleveland, United States)
COI
6
11:55
Lung function preservation in a phase 3 trial of tocilizumab (TCZ) in systemic sclerosis (SSc)
C. Denton(London, United Kingdom)
COI
7
12:05
Late Breaking Abstract - Safety and efficacy of B-cell depletion with rituximab for the treatment of systemic sclerosis-associated pulmonary arterial hypertension.
R. Zamanian(Portola Valley, United States)
COI
8
12:15
Late Breaking Abstract - Transbronchial lung cryobiopsy for interstitial lung disease diagnosis: results of the COLDICE Study
L. Troy(Camperdown (NSW), Australia)
COI
9
12:25
Wrap-up by discussant and discussion
M. Kreuter(Mainz, Germany)
COI
10
RCT
. . .